Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2924 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2023-08-17 | 2023-10-04 | 202265 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218132 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-02-01 | 218134 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218137 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-06-20 | 2024-10-15 | 230964 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2024-08-08 | 2024-11-21 | 234885 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2025-01-15 | 2025-05-09 | 247779 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2025-01-15 | 2025-05-15 | 247782 |
| TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2025-01-15 | 2025-05-15 | 247785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2017-08-21 | 2017-10-10 | 19944 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-05-29 | 113785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-FINASTERIDE | 5MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-11 | 272307 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-09-23 | 2021-11-25 | 146128 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-12-02 | 2022-05-05 | 150406 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2023-07-12 | 2025-03-20 | 198394 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 1MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258513 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-METFORMIN | 850MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258449 |
| TEVA-METFORMIN | 500MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258452 |
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258537 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258568 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258532 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258535 |
| TEVA-MODAFINIL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258732 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |